{"id":"https://genegraph.clinicalgenome.org/r/c3895ec5-822d-411e-a721-1405108b7f50v1.0","type":"EvidenceStrengthAssertion","dc:description":"Nonerythrocytic spectrin beta (SPTBN2) was first reported in relation to autosomal dominant spinocerebellar ataxia in 2006 (Ikeda et al., PMID: 16429157). Features of autosomal dominant *SPTBN2* related disease include but are not limited to: cerebellar ataxia, nystagmus, developmental delay, and cerebellar atrophy. Per criteria outlined by the ClinGen Lumping and Splitting guidelines, we found a difference in the molecular mechanism and inheritance pattern. Therefore, the following disease entities have been split into two disease entities: spinocerebellar ataxia 5 (OMIM:600224), spinocerebellar ataxia recessive 14 (OMIM:615386). The split curation for autosomal recessive *SPTBN2* related spinocerebellar ataxia has been curated separately. 16 variants (14 missense and 2 in-frame indels that have been reported in 18 probands in 9 publications (PMIDs: 16429157, 25981959, 22914369, 31617442, 31066025, 31721007, 30898343, 29915382, 33801522) are included in this curation. Segregation in a large well phenotyped family with extensive genotyping yielded approximately 90 affected with consistent features and all affected members genotyped, carried the familial variant (PMID 16429157). More evidence is available in the literature, but the maximum score for genetic evidence has been reached. The mechanism of pathogenicity appears to be gain-of-function, though the precise nature of the altered function is unclear. This gene-disease relationship is also supported by an animal model, expression study and functional alteration assay (PMIDs: 9826670, 20603325, 25057192). Expression of a human patient derived variant nearly fully recapitulated the ataxia and cerebellar atrophy features in a mouse model and a cell-culture model in a mouse neuronal cell line (Neuro2a) showed disruption to sub-cellular localization. Further functional evidence was used to weight case-level evidence and suggested that at least one mechanism for disease could be related to an increase in variant *SPTBN2* binding affinity for actin (PMID: 37626910). In summary, there is definitive evidence supporting the relationship between *SPTBN2* and autosomal dominant spinocerebellar ataxia. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Cerebellar Ataxia GCEP on the meeting date Wednesday Sepetember 10, 2025 (SOP Version 11).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/c3895ec5-822d-411e-a721-1405108b7f50","GCISnapshot":"https://genegraph.clinicalgenome.org/r/634f17d6-d189-4141-a57f-998639db0a4f","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/634f17d6-d189-4141-a57f-998639db0a4f_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10155","date":"2025-09-10T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/634f17d6-d189-4141-a57f-998639db0a4f_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10155","date":"2025-09-10T20:21:17.809Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/634f17d6-d189-4141-a57f-998639db0a4f_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/634f17d6-d189-4141-a57f-998639db0a4f_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5e5afbb5-5c9b-4899-9892-d57932742c53","type":"EvidenceLine","dc:description":"The model nearly fully recapitulates the ataxia phenotype seen in human variant carriers and this was the result of expression the human gene in mouse purkinje cells only which would be consistent with the phenotype as well. The authors confirmed expression of the human protein since the relative abundance of SPTBN2 protein in the transgenic mice was not significantly higher thatn the background strain.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c409c02e-ef03-4180-a2e9-075b79366774","type":"Finding","dc:description":"Authors assert that the mice expression human variant SPTBN2 had results consistent with other mouse models of ataxia and that there was thinning of the cerebellar molecular layer which is consistent with the cerebellar atrophy seen in many affected human carriers","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25057192","rdfs:label":"Patient variant expression in SCA5 mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/634f17d6-d189-4141-a57f-998639db0a4f_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b860c5c7-3fbf-4f96-9011-25cbb6c564b3","type":"EvidenceLine","dc:description":"The assay shows disruption to sub-cellular localization for the variant and to an also suggests that the variant is causing the same mislocalization for WT protein","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c883194d-d536-46c2-9695-ccb9988408a1","type":"FunctionalAlteration","dc:description":"Cells transfected with the variant SPTBN2 localized to the golgi while cells with WT SPTBN2 localized to the cell surface. Further, when labelled variant and WT SPTBN2 were co-transfected, all of the signal still localized to the golgi and not the cell body demonstrating a potential dominant negative effect","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20603325","rdfs:label":"SPTBN2 variant Leu253Pro disrupted localization"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/634f17d6-d189-4141-a57f-998639db0a4f_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7292b091-00d7-44aa-8abb-2379b780eda3","type":"EvidenceLine","dc:description":"Score increased due to agreement significant expression in the brain and cerebellum while expression in other tissues is not absent, expression in the cerebellum is in line with the phenotypic spectrum of variant carriers in this curation","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f4d262e1-d34d-49a1-988b-7418d7314705","type":"Finding","dc:description":"Northern blot of RNA extracted from human tissue - shows heavy expression in the brain and confirms significant expression in the cerebellum.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9826670","rdfs:label":"Î²III spectrin expression in human brain","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5},{"id":"https://genegraph.clinicalgenome.org/r/634f17d6-d189-4141-a57f-998639db0a4f_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c3a9209b-0bab-4ec3-8b24-a15c0ed8c966","type":"EvidenceLine","dc:description":"absent from gnomAD v4.1","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c3a9209b-0bab-4ec3-8b24-a15c0ed8c966_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16429157","allele":{"id":"https://genegraph.clinicalgenome.org/r/5ccb18e5-8285-49ba-a445-9c035bd15839","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006946.4(SPTBN2):c.1886_1900del (p.Leu629_Arg634delinsTrp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1979829518"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/bdba82f9-51a3-4232-b714-0c9379bf9426","type":"EvidenceLine","dc:description":"absent from gnomAD v4.1","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bdba82f9-51a3-4232-b714-0c9379bf9426_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID 37626910 shows increased binding affinity for actin","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/bdba82f9-51a3-4232-b714-0c9379bf9426_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16429157","allele":{"id":"https://genegraph.clinicalgenome.org/r/57b74929-cf6e-4060-b216-73b3b0ea3423","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006946.4(SPTBN2):c.758T>C (p.Leu253Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA253456"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9c111215-994b-4b5b-bf60-05dfcefc8392","type":"EvidenceLine","dc:description":"Parents were screened for the variant found in the affected child but no method in the genotypic suggested that parental relationship was confirmed","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9c111215-994b-4b5b-bf60-05dfcefc8392_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31066025","allele":{"id":"https://genegraph.clinicalgenome.org/r/bf55274f-5297-4332-a5d7-af6b7c024a30","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006946.4(SPTBN2):c.1309C>T (p.Arg437Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA381481176"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/28e7a664-181a-4da0-a681-d84e3522d65e","type":"EvidenceLine","dc:description":"gnomAD v4.1 0.00004535 in the European non Finnish population - father is a carrier and asserted unaffected, the authors note that there has been observed a variable age of onset and genetic anticipation however that does not appear to be a widely accepted element of SPTBN2 related disease in the literature","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/28e7a664-181a-4da0-a681-d84e3522d65e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29915382","allele":{"id":"https://genegraph.clinicalgenome.org/r/b556882e-21d8-42b2-a16b-42a727b58595","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006946.4(SPTBN2):c.91T>C (p.Ser31Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6129777"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/786a2bc0-c8f0-4fd7-9ead-3abc74956d86","type":"EvidenceLine","dc:description":"absent from gnomAD v4.1","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/786a2bc0-c8f0-4fd7-9ead-3abc74956d86_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID 37626910 shows increased binding affinity for actin","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/786a2bc0-c8f0-4fd7-9ead-3abc74956d86_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31066025","allele":{"id":"https://genegraph.clinicalgenome.org/r/fc224dba-c4ef-4205-abb0-357b81dc7cd4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006946.4(SPTBN2):c.185C>T (p.Thr62Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA381484385"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c52aaea9-db1a-49e0-8044-5373aa80cb04","type":"EvidenceLine","dc:description":"absent from gnomAD v4.1","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c52aaea9-db1a-49e0-8044-5373aa80cb04_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID 37626910 shows increased binding affinity for actin","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/c52aaea9-db1a-49e0-8044-5373aa80cb04_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29915382","allele":{"id":"https://genegraph.clinicalgenome.org/r/aa164c93-668c-40af-8159-9ff10367325f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006946.4(SPTBN2):c.172G>A (p.Val58Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA381484419"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/506d0472-a43f-4041-bec2-6e033c3d30e3","type":"EvidenceLine","dc:description":"The variant is asserted de novo but there is no explanation of what data was used to make that claim","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/506d0472-a43f-4041-bec2-6e033c3d30e3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30898343","allele":{"id":"https://genegraph.clinicalgenome.org/r/39178d6d-d9b5-41b0-ab56-a12210bd08af","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006946.4(SPTBN2):c.1309C>G (p.Arg437Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA381481178"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/14fb4274-2f1a-41d3-92a6-59be3c580ddb","type":"EvidenceLine","dc:description":"Absent from gnomAD v4.1","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/14fb4274-2f1a-41d3-92a6-59be3c580ddb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33797620","allele":{"id":"https://genegraph.clinicalgenome.org/r/204925fb-4c52-4f50-b6df-077a7d38bd6c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006946.4(SPTBN2):c.486C>G (p.Ile162Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA381483529"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/5d033072-532c-4761-bfd8-60e50b81d8dc","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5d033072-532c-4761-bfd8-60e50b81d8dc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID - 25981959 decreased Na+ channel current in transfected primary rat hippocampal neuronal cultures","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/5d033072-532c-4761-bfd8-60e50b81d8dc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22914369","allele":{"id":"https://genegraph.clinicalgenome.org/r/bcb93e94-fc9e-4adb-8783-539d786ccd9e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006946.4(SPTBN2):c.1438C>T (p.Arg480Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA264227"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/634f17d6-d189-4141-a57f-998639db0a4f_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8932d40d-f4ae-4a7a-b2c9-abf89bf3b436_proband_segregation","type":"FamilyCosegregation","dc:description":"255 kb linkage region identified and transformed in to BAC library which was shotgun sequenced to find the SPTBN2 variant in the family","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16429157","rdfs:label":"LincolnFamily","estimatedLodScore":10.24,"family":{"id":"https://genegraph.clinicalgenome.org/r/8932d40d-f4ae-4a7a-b2c9-abf89bf3b436","type":"Family","rdfs:label":"LincolnFamily","member":{"id":"https://genegraph.clinicalgenome.org/r/28107a7b-e32d-41f9-9f60-826e206c7a77","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16429157","rdfs:label":"Ikeda_LincolnProband","allele":{"id":"https://genegraph.clinicalgenome.org/r/93ece128-1e7b-4591-9469-fe7d0926c23b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006946.4(SPTBN2):c.1596_1634del (p.Glu532_Met544del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA658658074"}},"detectionMethod":"After linkage analysis confirmed the locus of the variant and SPTBN2 was identified by shotgun sequencing in the American family, direct sequencing for the variant was used for family members, where all affecteds were carriers for the familial variant","firstTestingMethod":"Linkage analysis","phenotypeFreeText":"Phenotype data for the family are detailed in PMID 7874171 - phenotypes are presented in aggregate with no member singled out and detailed further as a proband - ages of onset range from 10yo to 68yo","phenotypes":["obo:HP_0001288","obo:HP_0001350","obo:HP_0001272","obo:HP_0002483"],"previousTesting":true,"previousTestingDescription":"Microsatellite markers used to confirm linkage to the suspected SCA5 region of chromosome 11 then a BAC library was made from the linkage region and then further refined to 255kb using microsatellite markers common to affected haplotypes in the the three families that were part of the report. The entire 255kb shared region was cloned in to a BAC library and shotgun sequenced. ","secondTestingMethod":"PCR","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/9680ccb9-7e94-44fd-aa58-f99732cb46ac_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16429157","allele":{"id":"https://genegraph.clinicalgenome.org/r/93ece128-1e7b-4591-9469-fe7d0926c23b"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Phenotype data for the family are detailed in PMID 7874171","phenotypePositiveAllelePositive":74,"phenotypes":["obo:HP_0001272","obo:HP_0001350","obo:HP_0002483","obo:HP_0001288"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/28107a7b-e32d-41f9-9f60-826e206c7a77"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/9680ccb9-7e94-44fd-aa58-f99732cb46ac","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9680ccb9-7e94-44fd-aa58-f99732cb46ac_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Transgenic mouse model with the variant recapitulates the ataxia phenotype and reduction in cerebellar cells PMID 25057192","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/9680ccb9-7e94-44fd-aa58-f99732cb46ac_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/dcbc2111-d63f-4213-8cad-953bbecfa739","type":"EvidenceLine","dc:description":"absent from gnomAD v4.1 - Parents were screened for the variant found in the affected child but no method in the genotypic suggested that parental relationship was confirmed","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dcbc2111-d63f-4213-8cad-953bbecfa739_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31066025","allele":{"id":"https://genegraph.clinicalgenome.org/r/a383c7f2-b120-4606-8675-31eebaf8614f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006946.4(SPTBN2):c.1310G>A (p.Arg437Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA381481174"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/7cc92dfc-47a9-4e7f-b9e4-f7f54872de8f","type":"EvidenceLine","dc:description":"absent from gnomAD v4.1","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7cc92dfc-47a9-4e7f-b9e4-f7f54872de8f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29915382","allele":{"id":"https://genegraph.clinicalgenome.org/r/86d4e0f7-3c71-4414-aee1-4505303b6504","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006946.4(SPTBN2):c.1043A>T (p.Asn348Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA208604"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/0f65a3c5-d43c-4467-b176-947025f76992","type":"EvidenceLine","dc:description":"absent from gnomAD v4.1 - Parents were screened for the variant found in the affected child but no method in the genotypic suggested that parental relationship was confirmed","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0f65a3c5-d43c-4467-b176-947025f76992_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID 37626910 shows increased binding affinity for actin","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/0f65a3c5-d43c-4467-b176-947025f76992_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31066025","allele":{"id":"https://genegraph.clinicalgenome.org/r/e71cfeec-b39e-42e6-9817-a0966e2a9488","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006946.4(SPTBN2):c.479T>G (p.Phe160Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA381483561"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/e3369819-8584-4d95-ab43-c4b344bffffa","type":"EvidenceLine","dc:description":"Trio-exome confirmed parental relationships - absent from gnomAD v4.1","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e3369819-8584-4d95-ab43-c4b344bffffa_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"decreased Na+ channel current in transfected primary rat hippocampal neuronal cultures","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/e3369819-8584-4d95-ab43-c4b344bffffa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25981959","allele":{"id":"https://genegraph.clinicalgenome.org/r/bcb93e94-fc9e-4adb-8783-539d786ccd9e"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/adc43bfa-8fc3-4f76-9057-30a1d0a455a3","type":"EvidenceLine","dc:description":"absent from gnomAD v4.1 - both parents were tested for the SPTBN2 variant and were not carriers","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/adc43bfa-8fc3-4f76-9057-30a1d0a455a3_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID 37626910 shows increased binding affinity for actin","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/adc43bfa-8fc3-4f76-9057-30a1d0a455a3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31721007","allele":{"id":"https://genegraph.clinicalgenome.org/r/b2ea7c3d-ff66-4e3a-bb5e-53c826192d00","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006946.4(SPTBN2):c.812C>T (p.Thr271Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA381482753"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/596c6f68-25ab-42ee-9b11-75742e6e7d90","type":"EvidenceLine","dc:description":"absent from gnomAD v4.1","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/596c6f68-25ab-42ee-9b11-75742e6e7d90_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID 37626910 shows increased binding affinity for actin","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/596c6f68-25ab-42ee-9b11-75742e6e7d90_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33801522","allele":{"id":"https://genegraph.clinicalgenome.org/r/55171fbc-c796-419a-85df-52da9e8ae8df","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006946.4(SPTBN2):c.193A>G (p.Lys65Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA381484370"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/82e0d213-4008-400c-8b28-3441d7932588","type":"EvidenceLine","dc:description":"Single allele in gnomAD v4.1 in the remaining category - REVEL score is very low 0.116","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/82e0d213-4008-400c-8b28-3441d7932588_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33797620","allele":{"id":"https://genegraph.clinicalgenome.org/r/aeb2e0ed-7a86-4e3b-91dd-c0cc557d5d23","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006946.4(SPTBN2):c.2648G>T (p.Arg883Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6129076"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/c7ccb1f3-c9e3-47a5-9bac-f309dc1f5d60","type":"EvidenceLine","dc:description":"absent from gnomAD v4.1 - de novo asserted but parental relationships not confirmed","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c7ccb1f3-c9e3-47a5-9bac-f309dc1f5d60_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID 37626910 shows increased binding affinity for actin","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/c7ccb1f3-c9e3-47a5-9bac-f309dc1f5d60_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29915382","allele":{"id":"https://genegraph.clinicalgenome.org/r/5eddc17f-644f-4a1b-addc-55f6a514e013","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006946.4(SPTBN2):c.181A>G (p.Lys61Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA205211"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/a4da0987-6a62-493e-84cf-75bc2e8cb21e","type":"EvidenceLine","dc:description":"absent from gnomAD v4.1","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a4da0987-6a62-493e-84cf-75bc2e8cb21e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID 37626910 shows increased binding affinity for actin","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/a4da0987-6a62-493e-84cf-75bc2e8cb21e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33801522","allele":{"id":"https://genegraph.clinicalgenome.org/r/e4aa849f-fcea-4019-ab6f-f3b20c7290d1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006946.4(SPTBN2):c.764A>G (p.Asp255Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA381482877"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/e9855279-79a4-4943-90a4-f9a9f9f1d074","type":"EvidenceLine","dc:description":"absent from gnomAD v4.1","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9855279-79a4-4943-90a4-f9a9f9f1d074_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31617442","allele":{"id":"https://genegraph.clinicalgenome.org/r/a383c7f2-b120-4606-8675-31eebaf8614f"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":11665,"specifiedBy":"GeneValidityCriteria11","strengthScore":17,"subject":{"id":"https://genegraph.clinicalgenome.org/r/1b5U1Y1TMFY","type":"GeneValidityProposition","disease":"obo:MONDO_0010848","gene":"hgnc:11276","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_634f17d6-d189-4141-a57f-998639db0a4f-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}